Skip to main content
Premium Trial:

Request an Annual Quote

Innogenetics to Distribute Third Wave Invader Products in Europe

NEW YORK, April 27 (GenomeWeb News) - Third Wave Technologies, of Madison, Wisc., and Innogenetics, of Gent, Belgium, announced today that they have signed a four-year European marketing and distribution agreement for Third Wave Invader molecular diagnostic products.

 

Under the terms of the agreement, Innogenetics receives exclusive European marketing and distribution rights for select Invader products relating to genetic testing of risk factors for cardiovascular disease, blood coagulation, and healing disorders, the companies said.

 

In addition, the companies said, Innogenetics may distribute other new genetics-related tests developed by Third Wave in the future.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.